foselutoclax
foselutoclax: 1 clinical trial tracked.
foselutoclax evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about foselutoclax, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With Diabetic Macular Edema
Primary endpoint: Mean Change From Baseline to Average of Week 20 and Week 24 in BCVA by ETDRS Letter
InterventionalRandomizedtriple52 enrolledStarted 2023-08Completion 2025-0419 sites · United StatesUnity Biotechnology, Inc.